Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ERTEMIS: Edoxaban in Atrial Fibrillation with Mitral Stenosis
KCT0006484Phase 2Not yet recruiting
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of edoxaban in Atrial fibrillation (AFib), mitral stenosis (MS), sponsored by Daiichi Sankyo Co., Ltd.. Planned start Aug 2021; status: not yet recruiting.
02
Drugs
edoxaban
03
Conditions
Atrial fibrillation (AFib)mitral stenosis (MS)
Beyond the preview
Go deeper on KCT0006484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0006484.